Apart from promoting T-cell effector response, the study by Forte et al. shows, with a mouse melanoma model, that administration of CD73 inhibitor also increases tumor-infiltrating B-cells, thus suppressing tumor growth [27]. Here, NT5E is linked to neoplasm.